Stock Exchange Release

Free for publication on December 13, 2021 at 1.00 pm (CET+1)

Bittium Corporation’s Financial Calendar for the Year 2022

In 2022, Bittium Corporation will publish its half year financial report, annual financial report, and Business Reviews from the financial periods of January-March and January-September. The structure of the Business Reviews will be lighter than that of the financial reports.

In 2022, Bittium Corporation will publish its half year financial report and Financial Statement Bulletin as follows:

• Financial Statement Bulletin 2021: on February 10, 2022, at 8.00 am (CET+1)
• Half Year Financial Report January – June 2022: on August 5, 2022, at 8.00 am (CEST+1)

In 2022, Bittium Corporation will publish its Business Reviews as follows:

• Business Review January-March 2022: on April 29, 2022 at 8.00 am (CET+1)
• Business Review January-September 2022: on October 21, 2022 at 8.00 am (CET+1)

Bittium Corporation observes a three-week silent period prior to announcing its financial reports. In 2022 the silent periods are as follows:

• January 20 - February 10, 2022
• April 8 – April 29, 2022
• July 15 – August 5, 2022
• September 30 – October 21, 2022

Bittium will release its annual report 2021 including Corporate Governance and Sustainability Report on March 16, 2022.

The Annual General Meeting will be held in Oulu, Finland on April 6, 2022.

Oulu, December 13, 2021

Bittium Corporation

Further information:

Karoliina Malmi
Vice President, Corporate Communications and Marketing
Tel. +358 40 344 2789

Distribution

Nasdaq Helsinki Oy
Main media

Bittium

Bittium specializes in the development of reliable, secure communications and connectivity solutions leveraging its over 35-year legacy of expertise in advanced radio communication technologies. Bittium provides innovative products and services, customized solutions based on its product platforms and R&D services. Complementing its communications and connectivity solutions, Bittium offers proven information security solutions for mobile devices and portable computers. Bittium also provides healthcare technology products and services for biosignal measuring in the areas of cardiology, neurology, rehabilitation, occupational health and sports medicine. Net sales in 2020 were EUR 78.4 million and operating profit was EUR 2.1 million. Bittium is listed on Nasdaq Helsinki. www.bittium.com

Files
Bittium Corporation's Financial Calendar for the Year 2022 (wkr0006.pdf)